The importance of patient information and informed consent for unlicensed phage therapy

Affiliations

¹ Edinburgh Medical School: Biomedical Sciences, University of Edinburgh, Edinburgh, UK; Countermeasures Development, Evaluation and Preparedness Division, UK Health Security Agency, Salisbury, UK. Electronic address: josh.jones@ed.ac.uk.
² Public Health, NHS Tayside, Dundee, UK.
³ Nuffield Department of Population Health, University of Oxford, Oxford, UK; Global Studies Centre, Gulf University for Science and Technology, Kuwait City, Kuwait.
⁴ Department of Paediatric Respiratory and Sleep Medicine, Royal Hospital for Children, Glasgow, UK; School of Medicine, University of Glasgow, Glasgow, UK.

Joshua D Jones et al. Clin Microbiol Infect. 2025.

. 2025 Aug 6:S1198-743X(25)00373-8.

doi: 10.1016/j.cmi.2025.07.032. Online ahead of print.

¹ Edinburgh Medical School: Biomedical Sciences, University of Edinburgh, Edinburgh, UK; Countermeasures Development, Evaluation and Preparedness Division, UK Health Security Agency, Salisbury, UK. Electronic address: josh.jones@ed.ac.uk.
² Public Health, NHS Tayside, Dundee, UK.
³ Nuffield Department of Population Health, University of Oxford, Oxford, UK; Global Studies Centre, Gulf University for Science and Technology, Kuwait City, Kuwait.
⁴ Department of Paediatric Respiratory and Sleep Medicine, Royal Hospital for Children, Glasgow, UK; School of Medicine, University of Glasgow, Glasgow, UK.

No abstract available

Keywords: Bacteriophage; Informed consent; Patient information; Phage therapy.

LinkOut - more resources